HT
VKTX icon

HAP Trading’s Viking Therapeutics VKTX Stock Holding History

HAP Trading’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,000
Closed -$3.38K – 878
2024
Q1 		$3.38K Buy
+15,000
New +$667K ﹤0.01% 645
2019
Q3 		– Sell
-11,800
Closed -$8K – 1432
2019
Q2 		$8K Sell
11,800
-8,600
-42% -$73.5K ﹤0.01% 994
2019
Q1 		$12K Buy
+20,400
New +$171K ﹤0.01% 911

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HAP Trading's VKTX Position: Q2 2024 in Review

HAP Trading sold out of Viking Therapeutics (VKTX) in Q2 2024, closing a stake of 65,357 shares — an estimated $4.28M sold.

HAP Trading first reported a position in VKTX in Q4 2018 and held it in 2 quarters. The position peaked at $5.36M in Q1 2024. 387 funds tracked by Wall St. Rank hold VKTX as of Q2 2024.

  • HAP Trading reported no remaining Viking Therapeutics position as of Q2 2024 after selling out during the quarter.
  • HAP Trading sold 65,357 Viking Therapeutics shares in Q2 2024, an estimated $4.28M.
  • HAP Trading first reported a position in Viking Therapeutics in Q4 2018 and held it in 2 quarters.
  • HAP Trading's Viking Therapeutics position peaked at $5.36M in Q1 2024.
  • 387 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2024.

Based on HAP Trading's 13F filing for Q2 2024, filed 14 Aug 2024.